- Home
- DOCU vs RGC Comparison
DOCU vs RGC Comparison
Compare DOCU & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$49.61
HOLD
Current Price
$24.49
Company Overview
Basic Information| Metric | DOCU | RGC |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 11.5B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DOCU | RGC |
|---|---|---|
| Price | $49.61 | $24.49 |
| Analyst Decision | Hold | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $63.33 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 88.1K |
| Earning Date | 06-04-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.48 | N/A |
| Revenue | ★ $3,219,500,000.00 | N/A |
| Revenue This Year | $10.58 | N/A |
| Revenue Next Year | $7.33 | N/A |
| P/E Ratio | $32.76 | ★ N/A |
| Revenue Growth | ★ 8.16 | N/A |
| 52 Week Low | $40.16 | $9.39 |
| 52 Week High | $94.67 | $950.00 |
Technical Indicators
Market Signals| Indicator | DOCU | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 58.42 | 39.39 |
| Support Level | $44.43 | $21.81 |
| Resistance Level | $50.24 | $26.42 |
| Average True Range (ATR) | 2.03 | 2.10 |
| MACD | 0.22 | -0.46 |
| Stochastic Oscillator | 77.38 | 11.80 |
Price Performance
Historical Comparison DOCU
RGC
About DOCU DocuSign Inc.
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.